VHL and von Hippel-Lindau disease: Germline pathogenic mutations drive VHL syndrome, while in spRCC, VHL mutations or hypermethylation occur in approximately 90% of spRCC cases, leading to dysregulation of the hypoxia-inducible factor (HIF) pathway.1–4